Evidence map›Paper›PMID 30923605›Full record

ArticleThe Pan African medical journal2018

[Corticosurrenaloma: an exceptional cause of primary hyperaldosteronism].

Baha Zantour, Ines Charrada, Zohra Elati, Fatma Larbi Ammari, Fadia Boubaker, Sondes Arfa, Olfa Berriche, Wafa Alaya, Mohamed Habib Sfar

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Baha ZantourService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Ines CharradaService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Zohra ElatiService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Fatma Larbi AmmariService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Fadia BoubakerService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Sondes ArfaService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Olfa BerricheService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Wafa AlayaService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Mohamed Habib SfarService d'Endocrinologie et Médecine Interne, Hôpital Tahar Sfar, Mahdia, Tunisie.
Hôpital régional · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosurrenaloma is a rare malignant tumor of the adrenal gland that often secretes corticosteroids, sex steroids and precursors. Aldosterone-producing corticosurrenaloma is very rare, accounting for 1 case/10million inhabitants. We report the case of a 38-year old man presenting with severe arterial hypertension associated with deep hypokalaemia (2.2 mmol/L). Exploration showed primary hyperaldosteronism (aldosterone = 2645 pmol/l, aldosterone/renin ratio = 327 pmol/MUI), with hypersecretion of glucocorticoids. Abdominopelvic CT scan revealed left poorly differentiated and heterogeneous adrenal mass measuring 9cm, infiltrating into the surrounding adipose tissue and the diaphragm, extending into the left renal vein, with regional adenopathy and hepatic nodule measuring 4cm. The patient underwent radical nephrectomy followed by right hepatectomy two months after resulting in remission. A year after the patient developed lung metastases. This study highlights that corticosurrenaloma should be suspected in patients with primary aldosteronism despite its rarity.

Indexed as

Adrenal Gland NeoplasmsAdultAldosteroneGlucocorticoidsHepatectomyHumansHyperaldosteronismHypertensionHypokalemiaMaleNephrectomyAldosteroneGlucocorticoidsadrenalMalignant corticosurrenalomaprimary hyperaldosteronism

Identifiers

PMID30923605
PMCPMC6431414
OpenAlexW2893300739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.